TP53 and neoplasm: Future studies will reveal detailed mechanisms of the complex regulatory interplay between the tumor TP53 status and the immune landscape, including p53-mediated innate anti-tumor response and presentation of mutant p53 neoantigens for eliciting immune recognition by T cell receptors.